scholarly journals In vitro and in vivo susceptibility of Salmonella spp. isolated from broiler chickens

2012 ◽  
Vol 22 (6) ◽  
pp. 1065-1068 ◽  
Author(s):  
Naser Ranjbar Malidareh ◽  
Sobhan Firouzi ◽  
Neda Ranjbar Malidareh ◽  
Hassan Habibi
2017 ◽  
Vol 65 (4) ◽  
pp. 289 ◽  
Author(s):  
M. ANDREOPOULOU (Μ. ΑΝΔΡΕΟΠΟΥΛΟΥ) ◽  
V. TSIOURIS (Β. ΤΣΙΟΥΡΗΣ) ◽  
I. GEORGOPOULOU (Ι. ΓΕΩΡΓΟΠΟΥΛΟΥ)

Organic acids are studied as candidate alternatives to antibiotic growth promoters. Their action is related to the pH reduction of the intestinal digesta, affecting the gut ecosystem in numerous ways. Intestinal microbiota can be altered as a result of the remarkable antibacterial activity of organic acids and the growth enhancement of non-pathogenic beneficial microorganisms, due to exclusive competition. Antibacterial activity has been widely reported for many poultry pathogens, such as Salmonella spp., Escherichia coli, Clostridium perfringens, Campylobacter spp., both in vitro and in vivo. However, it seems to depend on many factors concerning the weak acid used and the gut ecosystem. Apart from the microbiota, diet supplementation of organic acids has trophic effects on the intestinal mucosa, modifying the morphologic characteristics of intestinal villi and crypts and maintaining epithelial integrity. Furthermore, as found recently, organic acids have anti-inflammatory and immunostimulating properties. Diet acidification increases gastric proteolysis and the utilization of proteins and amino acids, affects pancreatic secretions and mineral absorption. There are also reports for an effect on appetite and palatability of the feed. All these properties attributed to organic acids have either a direct or indirect effect on the performance and health, even though the results presented for poultry lack consistency. Nonetheless, the benefits of organic acids can have practical application in the control of clinical and subclinical conditions, but more research is needed to study these perspectives.


2006 ◽  
Vol 85 (9) ◽  
pp. 1576-1583 ◽  
Author(s):  
C. Jansen van Rensburg ◽  
C.E.J. Van Rensburg ◽  
J.B.J. Van Ryssen ◽  
N.H. Casey ◽  
G.E. Rottinghaus

2021 ◽  
Vol 14 (2) ◽  
pp. 523-536
Author(s):  
Essam S. Soliman ◽  
Rania T. Hamad ◽  
Mona S. Abdallah

Background and Aim: Probiotics improve intestinal balance through bacterial antagonism and competitive exclusion. This study aimed to investigate the in vitro antimicrobial activity, as well as the in vivo preventive, immunological, productive, and histopathological modifications produced by probiotic Bacillus subtilis. Materials and Methods: The in vitro antimicrobial activities of B. subtilis (5×106 CFU/g; 0.5, 1.0*, 1.5, and 2.0 g/L) were tested against Escherichia coli O157: H7, Salmonella Typhimurium, Candida albicans, and Trichophyton mentagrophytes after exposure times of 0.25, 0.5, 1, and 2 h using minimal inhibitory concentration procedures. A total of 320 1-day-old female Ross broiler chickens were divided into five groups. Four out of the five groups were supplemented with 0.5, 1.0*, 1.5, and 2.0 g/L probiotic B. subtilis from the age of 1 day old. Supplemented 14-day-old broiler chickens were challenged with only E. coli O157: H7 (4.5×1012 CFU/mL) and S. Typhimurium (1.2×107 CFU/mL). A total of 2461 samples (256 microbial-probiotic mixtures, 315 sera, 315 duodenal swabs, and 1575 organs) were collected. Results: The in vitro results revealed highly significant (p<0.001) killing rates at all-time points in 2.0 g/L B. subtilis: 99.9%, 90.0%, 95.6%, and 98.8% against E. coli, S. Typhimurium, C. albicans, and T. mentagrophytes, respectively. Broilers supplemented with 1.5 and 2.0 g/L B. subtilis revealed highly significant increases (p<0.01) in body weights, weight gains, carcass weights, edible organs' weights, immune organs' weights, biochemical profile, and immunoglobulin concentrations, as well as highly significant declines (p<0.01) in total bacterial, Enterobacteriaceae, and Salmonella counts. Histopathological photomicrographs revealed pronounced improvements and near-normal pictures of the livers and hearts of broilers with lymphoid hyperplasia in the bursa of Fabricius, thymus, and spleen after supplementation with 2.0 g/L B. subtilis. Conclusion: The studies revealed that 1.5-2.0 g of probiotic B. subtilis at a concentration of 5×106 CFU/g/L water was able to improve performance, enhance immunity, and tissue architecture, and produce direct antimicrobial actions.


2017 ◽  
Vol 5 (1) ◽  
pp. 11 ◽  
Author(s):  
Mohamed Elbadawy ◽  
Mohamed Aboubakr

The aim of present study was to determine the pharmacokinetics and tissue residues of tilmicosin phosphate (tilmicoral®) as well as its in vitro and in vivo evaluation for control of Mycoplasma gallisepticum (MG) infection in broiler chickens. Pharmacokinetics (single oral dose) and tissues residues (daily for five days) of tilmicosin (25 mg/kg b.wt) in broilers were investigated. Peak plasma concentration of tilmicosin was 1.25±0.0.09 μg/mL and achieved at 3.15±0.34 h. Elimination half-life was long (44.3±7.22 h) and Vdarea was large (1.25±0.082 L/kg). Residue study revealed a good distribution and penetration of tilmicosine in lung, liver, kidney and muscles. Tilmicosin could not be detected in all tested tissues (except in lung) at 6 days after last administration. The MIC of tilmicosin and tylosin against MG were 0.054 and 0.319 μg/mL, respectively. MG infected chickens and treated by tilmicosin or tylosin showed a significant (p<0.05) improvement in mean body weights gain and a significant (p<0.05) decline in mean clinical signs score, air sac lesion score and mortality rate, however tilmicosin was a superior drug. In conclusion, timicoral® was a very effective medication for controlling MG infection in broiler chickens due to its rapid absorption, long elimination half-life, rapid and extensive penetration from blood into tissues especially lungs and air sacs. Additionally, tilmicoral® had a short withdrawal time. Moreover, its superior efficacy (in vitro and in vivo) against MG.


2019 ◽  
Vol 54 (2) ◽  
pp. 139-146 ◽  
Author(s):  
MA Kilani ◽  
AZ Hassan ◽  
ST Fadason ◽  
AM Obalowu ◽  
A Aliyu ◽  
...  

Phytochemical constituents of Croton lobatus L. (C. lobatus) water extracts and quantitative analysis were carried out following standard procedures. The antibacterial activity against Staphylococcus aureus (ATCC 33591); Streptococcus Spp; Pseudomonas aeruginosa (ATCC 9028); Proteus vulgaris; Escherichia coli (ATCC 43895); and Salmonella Spp (ATCC 4932) was carried out at the concentration of 0.5g/mL, 0.05 g/mL and 0.00 5g/mL of water. In vivo antimicrobial assay was carried out by creating four wounds of 0.5 by 0.5 cm on dorsal surface of a male albino rat under anesthesia. The wounds were left for 48 hrs, after which they were accessed and samples were collected for culture, identification and colony forming unit counts (CFU). Respective treatment using dried C. lobatus, C. lobatus (water extract), Physiological saline solution and Cicatrin powder was carried out and samples were collected at day one, three, five and seven after initiation of treatments for CFU counts on nutrient and MacConkey agar. The phytochemical studies revealed that C. lobatus contains carbohydrates, glycoside, saponins, steroids, triterpenes, flavonoids, alkaloids and tannins. Croton lobatus L. showed a dose dependent activity against micro organisms with C. lobatus 0.5 inhibited the growth of most bacteria at the zone of inhibition ≤ 21mm. This was also supported by in vivo antimicrobial assay. Secondary metabolite tannins, triterpenoids, flavonoids, crotonic acids and saponin were responsible for its antimicrobial activity against the tested microorganisms thereby supporting its usage by the traditional medicine practitioner in Nigeria to treat chronic wounds. Bangladesh J. Sci. Ind. Res.54(2), 139-146, 2019


2012 ◽  
Vol 3 (2) ◽  
pp. 137-144 ◽  
Author(s):  
F. Vieira de Souza ◽  
R. Roque ◽  
J.L. Silva Moreira ◽  
M. Resende de Souza ◽  
J.R. Nicoli ◽  
...  

The aim of this study was to assess the potential horizontal transfer of genetic traits for antibiotic resistance between lactobacilli isolated from the chicken gut, both in vitro and in vivo. Thirty-seven Lactobacillus spp. strains isolated from the gizzard, small and large intestines and caeca of free-range broiler chickens showed multi-drug resistance as assessed by disc diffusion assays. The minimum inhibitory concentration (MIC) for vancomycin, tetracycline, erythromycin and chloramphenicol was determined in De Man, Rogosa and Sharpe broth in a microplate assay. Almost all the lactobacilli isolates were resistant to vancomycin (except strains belonging to the Lactobacillus acidophilus group) and to tetracycline (MIC≥128 μg/ml). Only five strains were resistant to erythromycin, and six to chloramphenicol. The transfer rate in filter mating experiments performed using L. acidophilus strain 4M14E (EmR), Lactobacillus vaginalis strain 5M14E (CmR), Lactobacillus salivarius strain 5C14C (EmR), and the 4G14L and 3C14C strains of Lactobacillus reuteri (CmR) showed a frequency of approximately 1×104 cfu/ml of double-resistant transconjugants for the different combinations. The exception was the L. salivarius 5C14C (EmR) and L. vaginalis 5M14E (CmR) mating combination, which produced no transconjugants. In vivo experiments performed in gnotobiotic mice by mating L. acidophilus 4M14E (EmR) with L. reuteri 3C14C (CmR), L. reuteri 4G14L (CmR) or L. vaginalis 5M14E (CmR) resulted in transconjugants at 3.95±0.29, 3.16±0.33, and 4.55±1.52 log10 cfu/g of faeces, respectively. Taken together, these data suggest that genetic exchange may occur between native bacterial strains within the gastrointestinal tract of chickens, which might maintain a dynamic gene pool conferring antibiotic resistance upon indigenous microbiota components, even in the absence of the pathogens. This possibility must be taken into account as a complementary criterion when lactobacilli are screened for probiotic use.


2017 ◽  
Vol 81 (1) ◽  
pp. 68-78 ◽  
Author(s):  
Shengan Wang ◽  
Jiaying Yao ◽  
Bo Zhou ◽  
Jiaxin Yang ◽  
Maria T. Chaudry ◽  
...  

ABSTRACT Quercetin, a ubiquitous flavonoid, is known to have antibacterial effects. The purpose of this study was to investigate the effect of quercetin on cecal microbiota of Arbor Acre (AA) broiler chickens in vivo and the bacteriostatic effect and antibacterial mechanism of quercetin in vitro. In vivo, 480 AA broilers (1 day old) were randomly allotted to four treatments (negative control and 0.2, 0.4, or 0.6 g of quercetin per kg of diet) for 42 days. Cecal microbial population and distribution were measured at the end of the experiment. The cecal microflora in these broilers included Proteobacteria, Fimicutes, Bacteroidetes, and Deferribacteres. Compared with the negative control, quercetin significantly decreased the copies of Pseudomonas aeruginosa (P &lt; 0.05), Salmonella enterica serotype Typhimurium (P &lt; 0.01), Staphylococcus aureus (P &lt; 0.01), and Escherichia coli (P &lt; 0.01) but significantly increased the copies of Lactobacillus (P &lt; 0.01), Bifidobacterium (P &lt; 0.01), and total bacteria (P &lt; 0.01). In vitro, we investigated the bacteriostatic effect of quercetin on four kinds of bacteria (E. coli, P. aeruginosa, S. enterica Typhimurium, and S. aureus) and the antibacterial mechanism of quercetin in E. coli and S. aureus. The bacteriostatic effect of quercetin was stronger on gram-positive bacteria than on gram-negative bacteria. Quercetin damaged the cell walls and membranes of E. coli (at 50 × MIC) and S. aureus (at 10 × MIC). Compared with the control, the activity of the extracellular alkaline phosphatase and β-galactosidase and concentrations of soluble protein in E. coli and S. aureus were significantly increased (all P &lt; 0.01), and the activity of ATP in S. aureus was significantly increased (P &lt; 0.01); however, no significant change in ATP activity in E. coli was observed (P &gt; 0.05). These results suggest that quercetin has potential as an alternative antibiotic feed additive in animal production.


2018 ◽  
Vol 3 (1) ◽  
pp. 72 ◽  
Author(s):  
Odette J. Bernasconi ◽  
Valentina Donà ◽  
Regula Tinguely ◽  
Andrea Endimiani

Background: Salmonella and Shigella spp. are 2 of the most frequent and deadly enteric bacterial pathogens recorded worldwide. In developing countries Salmonella infections are responsible for many deaths annually and these mortality rates are prone to increase due to the emergence of resistance to antibiotics. In this overall scenario new alternative therapeutic approaches are needed.Methods: For the first time, we investigated the activity of 3 commercial bacteriophage cocktails (INTESTI, Septaphage, PYO) against a collection of contemporary Salmonella spp. (n = 30) and Shigella spp. (n = 20) strains isolated in Switzerland. Phage susceptibility was determined by implementing the spot test.Results: The overall susceptibility of Salmonella spp. to INTESTI and Septaphage was 87% and 77%, respectively. With regard to Shigella spp., the overall susceptibility to INTESTI and Septaphage was 95% and 55%, respectively. PYOwas observed to be active against only 10% of Salmonella spp. but against 95% of Shigella spp.Conclusions: Our results seem promising, especially for the INTESTI biopreparation against Salmonella enterica infections. Nevertheless, such speculation should be supported by further in vivo studies to confirm efficacy and safety of the cocktails. We also emphasize the importance of large in vitro screening analyses aimed to assess the activity of such biopreparations against contemporary multidrug-resistant strains that are emerging worldwide.Keywords: commercial; bacteriophages; Salmonella; Shigella cocktails


2019 ◽  
Author(s):  
Boris LEGBA ◽  
Victorien DOUGNON ◽  
Carène GBAGUIDI ◽  
Alidah ANIAMBOSSOU ◽  
Esther DEGUENON ◽  
...  

Abstract Background Uvaria chamae (Annonaceae), Phyllantus amarus (Phyllantaceae) and Lantana camara (Verbenaceae) are empirically alleged to be used as Beninese medicinal plants in the treatment of salmonellosis. This study aimed to produce scientific data on in vitro and in vivo efficacy of Uvaria chamae, Lantana camara and Phyllantus amarus on multiresistant Salmonella spp isolated in Benin.Results After in vitro tests on aqueous and ethanolic extracts of Uvaria chamae, Lantana camara and Phyllantus amarus , only the aqueous extract of Uvaria chamae (leaves) showed the best anti- Salmonella ’s activity. It has been used for the following experiments. The induction of salmonellosis revealed 9.0 10 8 CFU/ml was optimal concentration for triggering and maintaining the symptoms in chicks. This infective concentration has been used for in vivo assessment. 24 hours post inoculation later, the symptoms of salmonellosis (wet cloaca, diarrhea stool and somnolence) were observed in infected groups. After seven days of treatment, the rate of reduction of bacterial load at 100 mg / L, 200 mg / L, 400 mg / L of this extract was 85%, 52.38% and 98% respectively in the chicks groups infected with Salmonella Typhimurium ATCC 14028. About the groups infected with Salmonella spp (virulent strain), the rate of reduction of bacterial load at 100 mg / L, 200 mg / L, 400 mg / L of this extract was 0%, 98.66% and 99.33%. The toxicity tests did not show any significant effect of the Uvaria chamae ’s extract on the biochemical and hematological parameters of the chicks.Conclusion The aqueous extract of Uvaria chamae is active in vitro and in vivo on multiresistant strains of Salmonella spp . This plant is a good candidate for the development of an improved traditional medicine for the management of salmonellosis.


Sign in / Sign up

Export Citation Format

Share Document